NEW YORK, NY — In a move that marks a definitive turning point in the global fight...
Patient Advocacy and Support
TORONTO, ON – As medical advancements continue to improve survival rates for breast cancer patients, a secondary...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-like peptide-1 (GLP-1)...
NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a...
NEW YORK, NY – In a move that signals a new era for oncological philanthropy, Karen and...
TORONTO, ON – As the medical community continues to make strides in early detection and acute treatment...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor...
NEW YORK, NY — As the world enters the second week of October, a month traditionally dominated...
NEW YORK, NY — In a move that has sent shockwaves of optimism through the global scientific...
To the average observer, breast cancer is often viewed through a strictly feminine lens. The ubiquitous pink...
